Abstract
Obesity is characterized by excessive accumulation of fats in the adipose tissues. Accumulation of excess fat releases a large number of adipokines that can cause obesity and diabetes mellitus due to irregularity between demand and the production of insulin. Obesity affects many organs and influences the heart, liver, intestines, respiratory organs, endocrine, and reproductive functions. Polydipsia, polyuria, weight reduction, coronary illness, kidney injury, diabetic foot, and diabetic ketoacidosis are pathophysiological manifestations and complications of diabetes. Obesity and overweight also contribute to the immune system dysfunction due to increased secretion of pro-inflammatory cytokines which are also risk factors for many types of cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Shoumer, K. A., & Al-Essa, T. M. (2015). Is there a relationship between vitamin D with insulin resistance and diabetes mellitus? World Journal of Diabetes, 6(8), 1057.
Amasyali, B., Kose, S., Kursaklioglu, H., Kilic, A., & Isik, E. (2008). Leptin in acute coronary syndromes: Has the time come for its use in risk stratification? International Journal of Cardiology, 130(2), 264–265.
American College of Obstetricians and Gynecologists. (2013). ACOG Committee opinion No. 548: Weight gain during pregnancy. Obstetrics & Gynecology, 121, 210–212.
Angulo, P. (2007). Obesity and nonalcoholic fatty liver disease. Nutrition Reviews, 65, S57–S63.
Anyanwu, G. O., Kolb, A. F., & Bermano, G. (2020). Antiobesity functional leads and targets for drug development. In Egbuna et al. (Eds.), Phytochemicals as lead compounds for new drug discovery (pp. 143–160). https://doi.org/10.1016/b978-0-12-817890-4.00009-3.
Asferg, C., Møgelvang, R., Flyvbjerg, A., Frystyk, J., Jensen, J. S., Marott, J. L., et al. (2010). Leptin, not adiponectin, predicts hypertension in the Copenhagen City Heart Study. American Journal of Hypertension, 23(3), 327–333.
Ashcroft, F. M., Rohm, M., Clark, A., & Brereton, M. F. (2017). Is type 2 diabetes a glycogen storage disease of pancreatic β cells? Cell Metabolism, 26(1), 17–23.
Baumann, M., Von Eynatten, M., Dan, L., Richart, T., Kouznetsova, T., Heemann, U., & Staessen, J. A. (2009). Altered molecular weight forms of adiponectin in hypertension. The Journal of Clinical Hypertension, 11(1), 11–16.
Bayliss, G., Weinrauch, L. A., & D’Elia, J. A. (2012). Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy. Current Diabetes Reports, 12(4), 440–446.
Bhupathiraju, S. N., & Hu, F. B. (2016). Epidemiology of obesity and diabetes and their cardiovascular complications. Circulation Research, 118(11), 1723–1735.
Boulton, A. J., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., & Ziegler, D. (2005). Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care, 28(4), 956–962.
Care, D. (2019). Standards of medical care in diabetes 2019. Diabetes Care, 42, S81.
Cedergren, M. I. (2004). Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstetrics & Gynecology, 103(2), 219–224.
Chrysohoou, C., Panagiotakos, D. B., Pitsavos, C., Skoumas, I., Papademetriou, L., Economou, M., & Stefanadis, C. (2007). The implication of obesity on total antioxidant capacity in apparently healthy men and women: the ATTICA study. Nutrition, Metabolism and Cardiovascular Diseases, 17(8), 590–597.
Czech, M. P. (2017). Insulin action and resistance in obesity and type 2 diabetes. Nature Medicine, 23(7), 804–814.
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020). Diabetic ketoacidosis. Nature Reviews Disease Primers, 6(1), 1–20.
Egbuna, C., Palai, S., Ebhohimen, I. E., Mtewa, A. G., Ifemeje, J. C., Tupas, G. D., & Kryeziu, T. L. (2019). Screening of natural antidiabetic agents. Phytochemistry: An in-silico and in-vitro update (pp. 203–235). https://doi.org/10.1007/978-981-13-6920-9_11.
Fitter, S., & Zannettino, A. C. (2018). Osteopontin in the pathophysiology of obesity: Is Opn a fat cell foe?.
Fuchsberger, C., Flannick, J., Teslovich, T. M., Mahajan, A., Agarwala, V., & Gaulton, K. J. (2016). The genetic architecture of type 2 diabetes. Nature [Internet]., 536(7614), 41–47.
Gademan, M. G., Vermeulen, M., Oostvogels, A. J., Roseboom, T. J., Visscher, T. L., van Eijsden, M., et al. (2014). Maternal prepregancy BMI and lipid profile during early pregnancy are independently associated with offspring's body composition at age 5–6 years: the ABCD study. PLoS One, 9(4), e94594.
Gittelsohn, J., & Trude, A. (2017). Diabetes and obesity prevention: Changing the food environment in low-income settings. Nutrition Reviews, 75(Suppl. 1), 62–69.
Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., & Vandenberg, L. N. (2017). Metabolism disrupting chemicals and metabolic disorders. Reproductive Toxicology, 68, 3–33.
Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L. P., Hoehn, K. L., & Summers, S. A. (2007). Lipid mediators of insulin resistance. Nutrition Reviews, 65(Suppl. 1), S39–S46.
Hotamisligil, G. S. (2017). Inflammation, metaflammation and immunometabolic disorders. Nature, 542(7640), 177–185.
Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., & Lernmark, Å. (2017). Type 1 diabetes mellitus. Nature Reviews Disease Primers, 3(1), 1–17.
Laughlin, G. A., Barrett-Connor, E., May, S., & Langenberg, C. (2007). Association of adiponectin with coronary heart disease and mortality: The Rancho Bernardo study. American Journal of Epidemiology, 165(2), 164–174.
Levian, C., Ruiz, E., & Yang, X. (2014). The pathogenesis of obesity from a genomic and systems biology perspective. The Yale Journal of Biology and Medicine, 87(2), 113.
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007). Obesity induces a phenotypic switch in adipose tissue macrophage polarization. The Journal of Clinical Investigation, 117(1), 175–184.
Lumeng, C. N., & Saltiel, A. R. (2011). Inflammatory links between obesity and metabolic disease. The Journal of Clinical Investigation, 121(6), 2111–2117.
Major, G. C., Doucet, E., Trayhurn, P., Astrup, A., & Tremblay, A. (2007). Clinical significance of adaptive thermogenesis. International Journal of Obesity, 31(2), 204–212.
Mariappan, M. M., Prasad, S., D'Silva, K., Cedillo, E., Sataranatarajan, K., Barnes, J. L., & Kasinath, B. S. (2014). Activation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury. Journal of Biological Chemistry, 289(51), 35363–35375.
Marinou, K., Tousoulis, D., Antonopoulos, A. S., Stefanadi, E., & Stefanadis, C. (2010). Obesity and cardiovascular disease: From pathophysiology to risk stratification. International Journal of Cardiology, 138(1), 3–8.
McCarthy, A., Hughes, R., Tilling, K., Davies, D., Davey Smith, G., & Ben-Shlomo, Y. (2007). Birth weight; postnatal, infant, and childhood growth; and obesity in young adulthood: Evidence from the Barry Caerphilly Growth Study. The American Journal of Clinical Nutrition, 86(4), 907–913.
McLaughlin, T., Ackerman, S. E., Shen, L., & Engleman, E. (2017). Role of innate and adaptive immunity in obesity-associated metabolic disease. The Journal of Clinical Investigation, 127(1), 5–13.
Nelson-Dooley, C., Della-Fera, M. A., Hamrick, M., & Baile, C. A. (2005). Novel treatments for obesity and osteoporosis: Targeting apoptotic pathways in adipocytes. Current Medicinal Chemistry, 12(19), 2215–2225.
Patalay, M., Lofgren, I. E., Freake, H. C., Koo, S. I., & Fernandez, M. L. (2005). The lowering of plasma lipids following a weight reduction program is related to increased expression of the LDL receptor and lipoprotein lipase. The Journal of Nutrition, 135(4), 735–739.
Peaceman, A. M., Clifton, R. G., Phelan, S., Gallagher, D., Evans, M., Redman, L. M., et al. (2018). Lifestyle interventions limit gestational weight gain in women with overweight or obesity: LIFE-Moms prospective Meta-Analysis. Obesity, 26(9), 1396–1404.
Pearl, R. L., Wadden, T. A., Hopkins, C. M., Shaw, J. A., Hayes, M. R., Bakizada, Z. M., et al. (2017). Association between weight bias internalization and metabolic syndrome among treatment-seeking individuals with obesity. Obesity, 25(2), 317–322.
Peng, Y., Yu, S., Li, H., Xiang, H., Peng, J., & Jiang, S. (2014). MicroRNAs: Emerging roles in adipogenesis and obesity. Cellular Signalling, 26(9), 1888–1896.
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014). The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature, 510(7503), 84–91.
Pugazhenthi, S., Qin, L., & Reddy, P. H. (2017). Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochimicaetbiophysicaacta (BBA)-Molecular Basis of Disease, 1863(5), 1037–1045.
Rankinen, T., & Bouchard, C. (2006). Genetics of food intake and eating behavior phenotypes in humans. Annual Review of Nutrition, 26, 413–434.
Rastelli, M., Knauf, C., & Cani, P. D. (2018). Gut microbes and health: A focus on the mechanisms linking microbes, obesity, and related disorders. Obesity, 26(5), 792–800.
Sanyal, S., Grimalt, J. O., Horvat, M., Johnstone, E., Maio, S., Polanska, K., & Annesi-Maesano, I. (2018). The environment-wide approach for the assessment of the effect of environmental stressors on overweight, obesity and diabetes: A Study on Singletons for the Heals Project. In ISEE Conference Abstracts (Vol. 2018, No. 1).
Saravanan, K., Egbuna, C., Averal, H. I., Kannan, S., Elavarasi, S., & Bahadur, B. (Eds.). (2020). Drug Development for Cancer and Diabetes: A Path to 2030 (1st ed.). Apple Academic Press. https://doi.org/10.1201/9780429330490.
Stothard, K. J., Tennant, P. W., Bell, R., & Rankin, J. (2009). Maternal overweight and obesity and the risk of congenital anomalies: A systematic review and meta-analysis. Journal of the American Medical Association, 301(6), 636–650.
Theodoropoulou, M., & Stalla, G. K. (2013). Somatostatin receptors: From signaling to clinical practice. Frontiers in Neuroendocrinology, 34(3), 228–252.
Tilg, H., Moschen, A. R., & Roden, M. (2017). NAFLD and diabetes mellitus. Nature Reviews Gastroenterology & Hepatology, 14(1), 32–42.
Tupas, G. D., Otero, M. C. B., Ebhohimen, I. E., Egbuna, C., & Aslam, M. (2020). Antidiabetic lead compounds and targets for drug development. Phytochemicals as Lead Compounds for New Drug Discovery, 127–141. https://doi.org/10.1016/b978-0-12-817890-4.00008-1.
Umpierrez, G. E. (2019). Diabetic ketoacidosis. In The diabetes textbook (pp. 619–627). Cham: Springer.
Votruba, S. B., & Jensen, M. D. (2007). Sex differences in abdominal, gluteal, and thigh LPL activity. American Journal of Physiology-Endocrinology and Metabolism, 292(6), E1823–E1828.
Wander, P. L., Hochner, H., Sitlani, C. M., Enquobahrie, D. A., Lumley, T., Lawrence, G. M., et al. (2014). Maternal genetic variation accounts in part for the associations of maternal size during pregnancy with offspring cardiometabolic risk in adulthood. PLoS One, 9(3), e91835.
Wang, Q., Liang, X., & Wang, S. (2013). Intra-islet glucagon secretion and action in the regulation of glucose homeostasis. Frontiers in Physiology, 3, 485.
Wardle, J., Carnell, S., Haworth, C. M., & Plomin, R. (2008). Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. The American Journal of Clinical Nutrition, 87(2), 398–404.
Waterland, R. A. (2008). Epigenetic epidemiology of obesity: application of epigenomic technology. Nutrition Reviews, 66(Suppl. 1), S21–S23.
Westerterp, K. R., Smeets, A., Lejeune, M. P., Wouters-Adriaens, M. P., & Westerterp-Plantenga, M. S. (2008). Dietary fat oxidation as a function of body fat. The American Journal of Clinical Nutrition, 87(1), 132–135.
Whitaker, R. C. (2004). Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics, 114(1), e29–e36.
Ye, J. (2013). Mechanisms of insulin resistance in obesity. Frontiers of Medicine, 7(1), 14–24.
Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14(2), 88.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Tufail, T. et al. (2021). Pathophysiology of Obesity and Diabetes. In: Egbuna, C., Hassan, S. (eds) Dietary Phytochemicals. Springer, Cham. https://doi.org/10.1007/978-3-030-72999-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-72999-8_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-72998-1
Online ISBN: 978-3-030-72999-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)